BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32893236)

  • 1. Effects of Body Weight on Bleeding and Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-2.
    Yamamoto K; Natsuaki M; Yoshikawa Y; Morimoto T; Shiomi H; Watanabe H; Kato T; Saito N; Kadota K; Ando K; Furukawa Y; Tamura T; Sakamoto H; Toyofuku M; Inada T; Inoko M; Suwa S; Onodera T; Ishii K; Kanamori N; Kimura T;
    Circ J; 2020 Sep; 84(10):1734-1745. PubMed ID: 32893236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Renal Dysfunction on the Risks for Ischemic and Bleeding Events in Patients With Atrial Fibrillation Receiving Percutaneous Coronary Intervention.
    Yamamoto K; Shiomi H; Morimoto T; Natsuaki M; Takeji Y; Watanabe H; Yoshikawa Y; Matsumura-Nakano Y; Shizuta S; Tanabe K; Ando K; Kadota K; Morino Y; Kozuma K; Nakagawa Y; Kimura T
    Am J Cardiol; 2020 Feb; 125(3):399-408. PubMed ID: 31771755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.
    Yamamoto K; Shiomi H; Morimoto T; Takeji Y; Yoshikawa Y; Natsuaki M; Watanabe H; Tada T; Tazaki J; Yamaji K; Tamura T; Ando K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T
    Catheter Cardiovasc Interv; 2021 May; 97(6):E758-E770. PubMed ID: 33064372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke.
    Natsuaki M; Morimoto T; Watanabe H; Nakagawa Y; Furukawa Y; Kadota K; Akasaka T; Hanaoka KI; Kozuma K; Tanabe K; Morino Y; Muramatsu T; Kimura T;
    J Am Heart Assoc; 2019 Nov; 8(22):e013356. PubMed ID: 31701821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic and Bleeding Events After First Major Bleeding Event in Patients Undergoing Coronary Stent Implantation.
    Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Yoshikawa Y; Tazaki J; Tada T; Watanabe H; Kato E; Toyofuku M; Inada T; Kaneda K; Takeda T; Sakai H; Yamamoto T; Eizawa H; Yamada M; Shinoda E; Mabuchi H; Shirotani M; Matsuda M; Takahashi M; Ishii K; Onodera T; Sakamoto H; Aoyama T; Miki S; Ando K; Kimura T;
    Am J Cardiol; 2022 Jan; 162():13-23. PubMed ID: 34706818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies.
    Yoshikawa Y; Shiomi H; Watanabe H; Natsuaki M; Kondo H; Tamura T; Nakagawa Y; Morimoto T; Kimura T
    Circulation; 2018 Feb; 137(6):551-562. PubMed ID: 28982692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2.
    Tokushige A; Shiomi H; Morimoto T; Ono K; Furukawa Y; Nakagawa Y; Kadota K; Ando K; Shizuta S; Tada T; Tazaki J; Kato Y; Hayano M; Abe M; Hamasaki S; Ohishi M; Nakashima H; Mitsudo K; Nobuyoshi M; Kita T; Imoto Y; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Circ Cardiovasc Interv; 2014 Aug; 7(4):482-91. PubMed ID: 25074253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan - From the CREDO-Kyoto Registry Cohort-2 and Cohort-3.
    Natsuaki M; Morimoto T; Shiomi H; Yamamoto K; Yamaji K; Watanabe H; Uegaito T; Matsuda M; Tamura T; Taniguchi R; Inoko M; Mabuchi H; Takeda T; Domei T; Shirotani M; Ehara N; Eizawa H; Ishii K; Tanaka M; Inada T; Onodera T; Nawada R; Shinoda E; Yamada M; Yamamoto T; Sakai H; Toyofuku M; Tamura T; Takahashi M; Tada T; Sakamoto H; Tada T; Kaneda K; Miki S; Aoyama T; Suwa S; Sato Y; Ando K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
    Circ J; 2022 Apr; 86(5):748-759. PubMed ID: 34526432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.
    Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T
    Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy and Bleeding Outcomes After Percutaneous Coronary Intervention.
    Yamamoto K; Morimoto T; Natsuaki M; Shiomi H; Ozasa N; Sakamoto H; Takeji Y; Domei T; Tada T; Taniguchi R; Uegaito T; Yamada M; Takeda T; Eizawa H; Suwa S; Shirotani M; Tamura T; Inoko M; Sakai H; Ishii K; Toyofuku M; Miki S; Onodera T; Furukawa Y; Inada T; Ando K; Kadota K; Nakagawa Y; Kimura T;
    Circ J; 2024 May; 88(6):888-899. PubMed ID: 37722886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of PARIS and CREDO-Kyoto Thrombotic and Bleeding Risk Scores on Clinical Outcomes in Patients With Acute Myocardial Infarction.
    Yamashita D; Saito Y; Sato T; Matsumoto T; Saito K; Wakabayashi S; Kitahara H; Sano K; Kobayashi Y
    Circ J; 2022 Mar; 86(4):622-629. PubMed ID: 34588393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary Intervention.
    Natsuaki M; Morimoto T; Shiomi H; Kadota K; Tada T; Takeji Y; Matsumura-Nakano Y; Yoshikawa Y; Watanabe H; Yamamoto K; Imada K; Domei T; Yamaji K; Kaneda K; Taniguchi R; Ehara N; Nawada R; Toyofuku M; Shinoda E; Suwa S; Tamura T; Inada T; Matsuda M; Aoyama T; Sato Y; Furukawa Y; Ando K; Nakagawa Y; Kimura T;
    Circ J; 2021 Oct; 85(11):1928-1941. PubMed ID: 33907052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3).
    Yamamoto K; Shiomi H; Morimoto T; Kadota K; Tada T; Takeji Y; Matsumura-Nakano Y; Yoshikawa Y; Imada K; Domei T; Kaneda K; Taniguchi R; Ehara N; Nawada R; Natsuaki M; Yamaji K; Toyofuku M; Kanemitsu N; Shinoda E; Suwa S; Iwakura A; Tamura T; Soga Y; Inada T; Matsuda M; Koyama T; Aoyama T; Sato Y; Furukawa Y; Ando K; Yamazaki F; Komiya T; Minatoya K; Nakagawa Y; Kimura T;
    Am J Cardiol; 2021 Apr; 145():47-57. PubMed ID: 33454345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of Baseline Hemoglobin Levels on Long-Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions.
    Nagao K; Watanabe H; Morimoto T; Inada T; Hayashi F; Nakagawa Y; Furukawa Y; Kadota K; Akasaka T; Natsuaki M; Kozuma K; Tanabe K; Morino Y; Shiomi H; Kimura T;
    J Am Heart Assoc; 2019 Nov; 8(22):e013703. PubMed ID: 31701786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Hayano M; Furukawa Y; Nakagawa Y; Tazaki J; Imai M; Yamaji K; Tada T; Natsuaki M; Saijo S; Funakoshi S; Nagao K; Hanazawa K; Ehara N; Kadota K; Iwabuchi M; Shizuta S; Abe M; Sakata R; Okabayashi H; Hanyu M; Yamazaki F; Shimamoto M; Nishiwaki N; Imoto Y; Komiya T; Horie M; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
    Am J Cardiol; 2012 Oct; 110(7):924-32. PubMed ID: 22721575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Combinations of the Patterns of Non-adherence to Anti-platelet Regimen in Stented Patients (PARIS) and Coronary Revascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) Thrombotic and Bleeding Risk Scores on Clinical Outcomes in Patients with Acute Myocardial Infarction.
    Yamashita D; Saito Y; Sato T; Matsumoto T; Suzuki S; Saito K; Wakabayashi S; Kitahara H; Sano K; Kobayashi Y
    Intern Med; 2024 Feb; 63(4):475-480. PubMed ID: 37344423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transradial vs. Transfemoral Percutaneous Coronary Intervention in Patients With or Without High Bleeding Risk Criteria.
    Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Watanabe H; Yamaji K; Watanabe H; Kato T; Saito N; Ando K; Kadota K; Furukawa Y; Kimura T;
    Circ J; 2020 Apr; 84(5):723-732. PubMed ID: 32188831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary Revascularization in the Past Two Decades in Japan (From the CREDO-Kyoto PCI/CABG Registries Cohort-1, -2, and -3).
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Kadota K; Yoshikawa Y; Yamaji K; Tada T; Tazaki J; Ehara N; Taniguchi R; Tamura T; Iwakura A; Tada T; Watanabe H; Suwa S; Toyofuku M; Inada T; Kaneda K; Ogawa T; Takeda T; Sakai H; Yamamoto T; Tambara K; Esaki J; Eizawa H; Yamada M; Shinoda E; Nishizawa J; Mabuchi H; Tamura N; Shirotani M; Nakayama S; Uegaito T; Matsuda M; Takahashi M; Inoko M; Kanemitsu N; Tamura T; Ishii K; Nawada R; Onodera T; Ohno N; Koyama T; Tsuneyoshi H; Sakamoto H; Aoyama T; Miki S; Tanaka M; Sato Y; Yamazaki F; Hanyu M; Soga Y; Komiya T; Ando K; Minatoya K; Kimura T
    Am J Cardiol; 2021 Aug; 153():20-29. PubMed ID: 34238444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.